Proteostasis Therapeutics stock skyrockets on positive trial results

Clinical stage biopharma company Proteostasis Therapeutics (PTI) announced positive preliminary results from a Phase 1 study for the treatment of cystic fibrosis (CF) patients. Shares of Proteostasis jumped more than … Continue reading Proteostasis Therapeutics stock skyrockets on positive trial results